Zobrazeno 1 - 10
of 1 134
pro vyhledávání: ''
Autor:
Gabriele Grassi, Loan Tung Thi Dang, Ngoc Bao Thi Dinh, Huy Minh Le, Nhan Chinh Lu Phan, Ai Xuan Holterman, Trinh Van Le, Minh Thanh Dang, Nhung Hai Truong
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:216-224
Background and Aim: Hepatic stellate cells (HSCs) activation, a critical event in liver fibrosis, has been recently shown to be related to autophagy. Determine whether chloroquine (CQ) could affect (i) the activation of HSC in vivo and (ii) the hepat
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:387-394
BACKGROUND AND AIM This study aimed to investigate the clinical benefits of locoregional radiation therapy (RT) before, after, and concurrent with sorafenib therapy for Barcelona Clinic Liver Cancer (BCLC) stage C hepatocellular carcinoma (HCC) patie
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:3308-3313
BACKGROUND AND AIM Vonoprazan has more potent and sustained acid inhibitory effects than proton pump inhibitors; therefore, Helicobacter pylori eradication rates are expected to improve with the use of vonoprazan-based regimens. To date, no randomize
Autor:
Sang Hoon Ahn, Soo-Young Park, Yeon Seok Seo, Won Young Tak, Yun Ho Roh, Mi Na Kim, Han Ah Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Beom Kyung Kim, Young Eun Chon, Hye Won Lee
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:200-207
BACKGROUND AND AIM Antiviral therapy (AVT) induces fibrosis regression in patients with chronic hepatitis B. We investigated long-term effects of entecavir (ETV) versus tenofovir (TDF) on fibrotic burden. METHODS Treatment-naive chronic hepatitis B p
Autor:
Mitsuhiro Shikamura, Yasuo Suzuki, Makoto Naganuma, Toshifumi Hibi, Jovelle Fernandez, Satoshi Motoya, Mamoru Watanabe, Takanori Kanai, Lyann Ursos, Tetsuharu Hori, Kenji Watanabe, Haruhiko Ogata, Shigeru Sakamoto, Toshiyuki Matsui
Publikováno v:
Journal of Gastroenterology and Hepatology. 37:81-88
BACKGROUND AND AIM This study aimed to determine the efficacy and safety of vedolizumab treatment with or without concomitant immunomodulator use in Japanese patients with moderate-to-severe ulcerative colitis. METHODS Among enrolled patients in a ph
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:38-85
Background and Aim: Drug-induced liver injury (DILI) can involve serious adverse reactions to many drug classes, causing a wide clinical and biochemical spectrum of liver injury. Despite a rise in prevalence and it being the most common cause of acut
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:91-132
Introduction: Vedolizumab has rarely been associated with pulmonary disease in patients with inflammatory bowel disease.1,2 Vedolizumab is a monoclonal antibody that inhibits α4β7-integrin on the surface of T lymphocytes from binding to mucosal vas
Autor:
Ming-Wun Wong, Lin Lin, Tso-Tsai Liu, Jui-Sheng Hung, William C. Orr, Wei-Yi Lei, Shu-Wei Liang, Chih-Hsun Yi, Chien-Lin Chen
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:3381-3386
Background and aim Opioid receptors agonists have been demonstrated to impair lower esophageal sphincter (LES) relaxation and induce spastic esophageal dysmotility, but little was known for their impact on distension-induced secondary peristalsis. Th
Autor:
Valentine Bordier, Fritz Murray, Joelle Buehler, Stéphanie Giezendanner, Daniel Pohl, Lukas Van Oudenhove, Valeria Schindler, Juliane Marie Hente
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:3322-3328
BACKGROUND AND AIM Previous studies have shown a reduction of gastrointestinal symptoms in irritable bowel syndrome (IBS) patients following a low FODMAP diet (LFD). It remains unknown which disorders of gut-brain interaction (DGBI) patients would be
Publikováno v:
Journal of Gastroenterology and Hepatology. 36:2640-2648
Background and aim Vedolizumab is a novel monoclonal antibody used in patients with inflammatory bowel disease, often affecting women of child-bearing age. We aimed to compare maternal and fetal adverse outcomes in pregnancies of women with inflammat